Actively Recruiting
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
Led by Cell Energy Life Sciences Group Co. LTD · Updated on 2025-08-12
150
Participants Needed
4
Research Sites
239 weeks
Total Duration
On this page
Sponsors
C
Cell Energy Life Sciences Group Co. LTD
Lead Sponsor
B
Beijing 302 Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for AIDS patients at late stage.
CONDITIONS
Official Title
Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed HIV infection
- Age between 18 and 65 years
- CD4+ T cell count below 500 cells/μl at baseline
- No serious AIDS-related events
- Able to understand and sign informed consent and comply with study requirements
- Agree not to participate in other studies or receive other immunotherapies during the study period
You will not qualify if you...
- Positive infection with HBV, HCV, HDV, or HEV based on virological testing
- Cytomegalovirus (CMV) or Epstein-Barr virus (EBV) viral load above 1000 copies/ml
- Infection with HIV-2
- Serious complications in organs such as kidney, heart, lungs, digestive system, endocrine, nervous, immune system, or tumors
- Long-term use of hormones or other immunosuppressive drugs
- Serious AIDS-related or unrelated events
- Use of immunosuppressive or systemic cytotoxic drugs for more than 3 months before recruitment
- Poor treatment compliance
- Drug addiction within last 6 months or positive urine drug test
- Participation in other clinical trials currently
- Pregnancy, breastfeeding, or fertility requirements
- Unable or unwilling to provide informed consent or comply with study requirements
- Other serious conditions that may interfere with the trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Beijing 302 Hospital
Beijing, China
Actively Recruiting
2
Beijing YouAn Hospital
Beijing, China
Actively Recruiting
3
Shenzhen Third People's Hospital
Shenzhen, China
Actively Recruiting
4
The Fifth Hospital of Shijiazhuang
Shijiazhuang, China
Actively Recruiting
Research Team
F
Fu-Sheng Wang, Doctor
CONTACT
R
Robert Chunhua Zhao, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here